NEW YORK/LOS ANGELES, July 26 (Reuters) - Amgen Inc. on Thursday posted quarterly profit that topped Wall Street expectations, even as sales of its biggest drug, Aranesp, fell 19 percent in the United States amid safety concerns.
NEW YORK/LOS ANGELES, July 26 (Reuters) - Amgen Inc. on Thursday posted quarterly profit that topped Wall Street expectations, even as sales of its biggest drug, Aranesp, fell 19 percent in the United States amid safety concerns.
